Company News
- [Press Releases] Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results
- [Media Focus] Preparing for post-pandemic while expanding biopharmaceutical capabilities
- [News Brief] Samsung Biologics shares 2023 business plans at 41st Annual J.P. Morgan Healthcare Conference
- [Press Releases] Samsung Biologics receives the Terra Carta Seal in recognition of the company’s commitment to creating a sustainable future